 |
市場調査レポート
商品コード
1373884
自己注射器の世界市場 (2023-2030年)：タイプ ・用途 ・エンドユーザー別の規模・シェア・成長分析・予測Global Auto Injector Market Size, Share, Growth Analysis, By Type, By Application, By End-user - Industry Forecast 2023-2030 |
||||||
| 自己注射器の世界市場 (2023-2030年)：タイプ ・用途 ・エンドユーザー別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月15日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の自己注射器の市場規模は、2021年の468億米ドル、2022年の563億米ドルから、予測期間中は17.9％のCAGRで推移し、2030年には2,473億米ドルの規模に成長すると予測されています。
近年、世界の自己注射器の市場は、慢性疾患の有病率の増加、自己投与デバイスに対する需要の高まり、技術の進歩など、さまざまな要因により大きな成長を遂げています。自己注射器は、使いやすさ、正確な投与、患者のコンプライアンスの向上など、いくつかの利点を提供します。
一方で、自己注射器のコストは、特に患者にとって経済的な負担が懸念される新興国において、市場成長の抑制要因となる可能性があります。従来の注射器と比較して自己注射器の価格が高いため、特定の市場での導入が制限される可能性があります。また、針刺し損傷のリスクが懸念されています。このような安全性への懸念が自己注射器の採用を制限する可能性があります。
当レポートでは、世界の自己注射器の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の自己注射器市場：タイプ別
- 市場概要
- 使い捨て
- 再利用可能
- 世界の自己注射器市場：用途別
- 市場概要
- 関節リウマチ
- 多発性硬化症
- アナフィラキシー
- その他
- 世界の自己注射器市場：エンドユーザー別
- 市場概要
- 在宅医療
- 病院・診療所
- その他
- 世界の自己注射器市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Becton, Dickinson and Company
- Eli Lilly and Company
- Johnson & Johnson
- Pfizer Inc.
- Amgen Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Ypsomed AG
- Antares Pharma, Inc.
- Bespak Europe Ltd. (A Consort Medical Company)
- Gerresheimer AG
- SHL Medical AG
- Owen Mumford Ltd.
- Enable Injections
- ScPharmaceuticals Inc.
- Biogen Inc.
- Novartis International AG
- Merck & Co., Inc.
- Consort Medical plc
- Haselmeier AG
Global Auto Injector Market size was valued at USD 46.8 billion in 2021 and is poised to grow from USD 56.30 billion in 2022 to USD 247.3 billion by 2030, at a CAGR of 17.9% during the forecast period (2023-2030).
Autoinjectors are medical devices designed to deliver a specific dose of medication to patients. They are often used for the self-administration of drugs, such as epinephrine for severe allergic reactions or insulin for diabetes management. In recent years, the global auto injector market has experienced significant growth due to various factors, including the increasing prevalence of chronic diseases, rising demand for self-administration devices, and advancements in technology. Auto injectors offer several benefits, such as ease of use, accurate dosing, and improved patient compliance. Key players in the auto injector market include pharmaceutical companies, medical device manufacturers, and technology providers. These companies often compete in terms of product features, design, safety, and compatibility with different medications. Market dynamics, such as regulatory requirements, reimbursement policies, and patent protection, also influence the market landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Auto-Injector Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Auto-Injector Market Segmental Analysis
The auto injectors market is segmented on the basis of type, application, end user, and region. By type, it is categorized into disposable and reusable auto injectors. Based on application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Auto-Injector Market Dynamics
Drivers of the Global Auto-Injector Market
Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases, such as rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, is a significant driver of the auto injector market. auto injectors offer a convenient and efficient way for patients to self-administer medications, empowering them to manage their conditions effectively.
There is a growing trend towards patient-centric healthcare, focusing on improving patient experience and promoting self-care. auto injectors provide patients with the ability to administer their medications at home, reducing the need for frequent hospital visits and enhancing their overall quality of life.
Restraints in the Global Auto Injector Market
High Cost of Auto Injectors
The cost of auto injector devices can be a restraint for market growth, particularly in emerging economies where affordability may be a concern for patients. The higher price of auto injectors compared to traditional syringes can limit their adoption in certain markets.
Despite the convenience they offer, auto injectors still involve needle usage, which can raise concerns about the risk of needlestick injuries. These safety concerns may limit their adoption, especially among patients who may be hesitant to self-administer injections.
Market Trends of the Global Auto Injector Key
The market is witnessing a notable trend towards self-administration of medications. Patients are increasingly seeking greater control and convenience in managing their treatment, leading to a rise in the adoption of auto injectors. These devices allow patients to self-administer medications accurately and easily, empowering them to take an active role in their healthcare journey.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Auto Injector Market by Type
- Market Overview
- Disposable and reusable auto injectors
- Global Auto Injector Market by Application
- Market Overview
- Rheumatoid arthritis
- multiple sclerosis
- anaphylaxis
- and others
- Global Auto Injector Market by End-user
- Market Overview
- Home care settings and hospitals & clinics others
- Global Auto Injector Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Antares Pharma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bespak Europe Ltd. (A Consort Medical Company), (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SHL Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Owen Mumford Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enable Injections (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ScPharmaceuticals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Consort Medical plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haselmeier AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
